Innoviva, Inc. (INVA) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $22.48 (+0.22%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 26, 2026 | Steve Seedhouse | Cantor Fitzgerald | $32.00 | +42.3% |
| Aug 11, 2025 | Trevor Allred | Oppenheimer | $35.00 | +55.7% |
Top Analysts Covering INVA
INVA vs Sector & Market
| Metric | INVA | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.40 |
| Analyst Count | 4 | 8 | 19 |
| Target Upside | +76.9% | +11474.9% | +17.1% |
| P/E Ratio | 3.74 | 3.91 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $107M | $109M | $111M | 3 |
| 2026-09-30 | $107M | $111M | $117M | 1 |
| 2026-12-31 | $112M | $116M | $122M | 2 |
| 2027-03-31 | $122M | $126M | $132M | 1 |
| 2027-06-30 | $129M | $134M | $140M | 2 |
| 2027-09-30 | $128M | $133M | $139M | 2 |
| 2027-12-31 | $134M | $139M | $145M | 1 |
| 2028-12-31 | $528M | $543M | $559M | 2 |
| 2029-12-31 | $568M | $608M | $642M | 1 |
| 2030-12-31 | $612M | $654M | $691M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.56 | $0.57 | $0.60 | 1 |
| 2026-09-30 | $0.32 | $0.34 | $0.36 | 1 |
| 2026-12-31 | $0.51 | $0.54 | $0.57 | 1 |
| 2027-03-31 | $0.51 | $0.54 | $0.57 | 1 |
| 2027-06-30 | $0.59 | $0.61 | $0.65 | 1 |
| 2027-09-30 | $0.56 | $0.59 | $0.63 | 1 |
| 2027-12-31 | $0.60 | $0.63 | $0.66 | 1 |
| 2028-12-31 | $1.62 | $2.00 | $2.38 | 2 |
| 2029-12-31 | $2.48 | $2.71 | $2.91 | 1 |
| 2030-12-31 | $1.68 | $1.84 | $1.97 | 1 |
Frequently Asked Questions
What is the analyst consensus for INVA?
The consensus among 4 analysts covering Innoviva, Inc. (INVA) is Buy with an average price target of $40.00.
What is the highest price target for INVA?
The highest price target for INVA is $35.00, set by Trevor Allred at Oppenheimer on 2025-08-11.
What is the lowest price target for INVA?
The lowest price target for INVA is $32.00, set by Steve Seedhouse at Cantor Fitzgerald on 2026-02-26.
How many analysts cover INVA?
4 analysts have issued ratings for Innoviva, Inc. in the past 12 months.
Is INVA a buy or sell right now?
Based on 4 analyst ratings, INVA has a consensus rating of Buy (2.00/5) with a +76.9% upside to the consensus target of $40.00.
What are the earnings estimates for INVA?
Analysts estimate INVA will report EPS of $0.57 for the period ending 2026-06-30, with revenue estimated at $109M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.